Guardant Health
GH
#1787
Rank
A$16.14 B
Marketcap
A$123.10
Share price
-3.96%
Change (1 day)
71.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.06

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.82. In 2024 the company made an earnings per share (EPS) of A-$5.18 an increase over its 2023 EPS that were of A-$6.23.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.06-2.27%
2024A-$5.18-16.82%
2023A-$6.23-33.13%
2022A-$9.3160%
2021A-$5.8255.04%
2020A-$3.75207.14%
2019A-$1.22-19.81%
2018A-$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$4.04-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.11-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA